Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Neurothesiometer

Discussion in 'Diabetic Foot & Wound Management' started by AALang, Dec 14, 2004.

  1. AALang

    AALang Member


    Members do not see these Ads. Sign Up.
    Is there any cosensus of opinion on how a neurothesiometer should be used, and what points of the foot should be tested?
    I have been unable to find any literature on this subject.
     
  2. Craig Payne

    Craig Payne Moderator

    Articles:
    8
    I stand to be corrected, but I don't think that there is any evidence to support what location(s) should be tested for VPT with the neurothesiometer or biothesiometer. There have been several sensitivity and specificity studies on locations with the monofilament.

    However, I just use medial 1st MPJ, lateral 5th MPJ and medial maleolus.
     
  3. Guldemond

    Guldemond Member

    Literature references VPT/neurothesiometer/biothesiometer

    Dear AALang,

    See references below.

    Best regards ,

    Sosenko JM, Kato M, Soto R, Bild DE.
    Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients.
    Diabetes Care. 1990 Oct;13(10):1057-61.
    PMID: 2209302 [PubMed - indexed for MEDLINE]

    J.P. Cassella, R.L. Ashford, V. Kavanagh-Sharp
    Effect of applied pressure in the determination of vibration
    sensitivity using the Neurothesiometer
    The Foot (2000) 10, 27–30

    Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG.
    Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Arch Intern Med. 1998 Feb 9;158(3):289-92.
    PMID: 9472210 [PubMed - indexed for MEDLINE]

    Armstrong DG, Hussain SK, Middleton J, Peters EJ, Wunderlich RP, Lavery LA.
    Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
    Ostomy Wound Manage. 1998 May;44(5):70-4, 76.
    PMID: 9697548 [PubMed - indexed for MEDLINE]

    Hagander LG, Midani HA, Kuskowski MA, Parry GJ.
    Quantitative sensory testing: effect of site and pressure on vibration thresholds.
    Clin Neurophysiol. 2000 Jun;111(6):1066-9.
    PMID: 10825714 [PubMed - indexed for MEDLINE]

    Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K.
    The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.
    Diabet Med. 2004 Jun;21(6):563-7.
    PMID: 15154940 [PubMed - indexed for MEDLINE]

    Chong PS, Cros DP.
    Technology literature review: quantitative sensory testing.
    Muscle Nerve. 2004 May;29(5):734-47. Review.
    PMID: 15116380 [PubMed - indexed for MEDLINE]

    Gin H, Rigalleau V, Baillet L, Rabemanantsoa C.
    Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.
    Diabetes Metab. 2002 Dec;28(6 Pt 1):457-61.
    PMID: 12522325 [PubMed - indexed for MEDLINE]

    Jirkovska A, Boucek P, Woskova V, Bartos V, Skibova J.
    Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics.
    J Diabetes Complications. 2001 Mar-Apr;15(2):63-8.
    PMID: 11274901 [PubMed - indexed for MEDLINE]

    Mayfield JA, Sugarman JR.
    The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes.
    J Fam Pract. 2000 Nov;49(11 Suppl):S17-29. Review.
    PMID: 11093555 [PubMed - indexed for MEDLINE]
     
Loading...

Share This Page